Welcome to our dedicated page for Milestone Scient SEC filings (Ticker: MLSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Milestone Scientific Inc. (MLSS) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations as a technology-focused medical research and development company. These SEC filings cover its activities in developing computerized injection technologies and instruments for medical, dental and cosmetic applications, including systems based on its DPS Dynamic Pressure Sensing Technology® platform.
On this page, you can review core periodic reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss Milestone Scientific’s dental and medical segments, its computer-controlled injection systems, and related risk factors. These filings also elaborate on topics referenced in company news releases, such as the STA® Single Tooth Anesthesia System, The Wand® STA System, and the CompuFlo® Epidural System, along with information about reimbursement developments and market activities where disclosed.
Current reports on Form 8-K are particularly relevant for tracking material events. Recent 8-K filings for Milestone Scientific include disclosures about leadership changes, compensation arrangements, notices from NYSE American regarding continued listing standards, and matters submitted to stockholders at the annual meeting, such as election of directors, amendments to the Restated Certificate of Incorporation to increase authorized shares of common stock, and ratification of independent auditors.
Stock Titan’s platform provides real-time updates as new Milestone Scientific filings are posted to EDGAR, along with AI-powered summaries that explain the key points of lengthy documents. Investors can quickly locate sections related to topics such as segment discussions, technology descriptions, stockholders’ equity, and governance proposals, as well as monitor any insider-related disclosures that may appear in Forms 3, 4 or 5. This helps users navigate Milestone Scientific’s regulatory history and understand the context behind its stock performance and strategic decisions.
Milestone Scientific (NYSE:MLSS) filed a routine Form 4 reporting two small open-market sales by 10 % owner BP4 S.r.l. The insider sold 10,056 shares on 06/16/2025 at $0.8951 and 1,693 shares on 06/18/2025 at $0.88, totaling 11,749 shares (≈ $10.5 K).
Following the transactions, BP4 S.r.l.’s beneficial ownership declined by less than 0.2 % to 9,447,183 common shares. No derivative trades or additional material changes were disclosed.